resting-heart-rate-biomarker

Resting Heart Rate (Vital-Sign Biomarker)

Resting heart rate (RHR) is a single-parameter physiological vital sign that integrates autonomic nervous system tone, cardiorespiratory fitness, and hemodynamic status into one non-invasive measurement. It is not a multi-feature composite clock — the clock-oriented frontmatter fields (n-cpgs-or-features, model-architecture, training-cohort) do not apply to a simple vital sign and are set to null. RHR predicts all-cause and cardiovascular mortality in dose-response fashion across multiple large prospective cohorts: each 10 beats/minute (bpm) increase in RHR is associated with roughly 9–17% higher all-cause mortality risk ^{1 2}. Beyond its prognostic value, RHR is the simulator’s cyclic-count driver for arterial elastin pulsatile fatigue — a higher resting rate means more cardiac cycles per unit time, contributing mechanistically to the cumulative pulsatile wall-stress burden on the aorta and large arteries. The sibling fitness biomarker is vo2max-biomarker, which reflects the same integrated autonomic/cardiorespiratory axis from the exercise-capacity direction.

Note on modality: vital-sign: RHR is classified under the vital-sign modality (added in schema R55) — single-parameter resting physiological measures that index aging/mortality risk but are neither multi-feature molecular clocks nor performance tests. The clock-feature fields (n-cpgs-or-features, model-architecture, training-cohort, test-retest-icc) are structurally not applicable here and are left null. The same modality applies to resting blood pressure, heart-rate variability, respiratory rate, and body temperature.

Identity and Measurement

• Definition: Heart rate measured at full rest — typically 5–15 minutes of supine or seated quiet rest, no recent physical activity or caffeine within 30 minutes
• Standard method: ECG R-R interval counting (gold standard) or palpation/pulse oximetry (acceptable for clinical use); wearable photoplethysmography (PPG) devices (smartwatches, chest straps) are widely used but carry meaningful inaccuracy during sleep and at rest, especially in those with irregular rhythms
• Normal range (adults, general population): 60–100 bpm (WHO/AHA definition); athletic populations commonly 40–60 bpm; values <40 bpm in non-athletes warrant evaluation
• Pre-analytical conditions: Supine or seated; ≥5 minutes of rest; no caffeine, exercise, or smoking within 1–2 hours; avoid immediately post-meal; morning measurement preferred for longitudinal tracking
• Wearable RHR: Consumer devices estimate RHR from resting overnight minimum or average; accuracy varies (~±5 bpm vs ECG); directionally useful for longitudinal trend monitoring but not clinically equivalent to manual ECG measurement

Aging Trajectory

RHR does not show a simple monotone decline with age. The intrinsic sinoatrial node firing rate decreases with age (reduced beta-adrenergic responsiveness, pacemaker cell loss), which would tend to lower RHR intrinsically. However, progressive reduction in parasympathetic (vagal) tone with aging — reflected in declining heart rate variability (HRV) — partially offsets this, resulting in:

• Modest RHR increase in sedentary individuals across middle age as vagal tone declines ³
• Blunting of the athlete’s bradycardia in older trained adults due to intrinsic SA-node aging
• Narrowing of the RHR gap between active and sedentary individuals in the very old (>80 years)

The autonomic determinants of RHR include:

• Parasympathetic (vagal) tone — dominant regulator of resting rate; higher vagal tone = lower RHR; declines with age and sedentary lifestyle
• Sympathetic tone — basal sympathetic drive sets the floor; rises with chronic stress, obesity, and heart failure
• Intrinsic SA node rate — approximately 90–100 bpm in the absence of autonomic input; declines slightly with age
• Cardiac filling and stroke volume — higher stroke volume (athlete heart) → lower heart rate to maintain cardiac output

Dose-Response: RHR and Mortality

Zhang 2016 — CMAJ meta-analysis (primary reference) ¹

The most comprehensive single meta-analysis of RHR and mortality in the general population:

• 46 prospective studies, n=1,246,203 participants, 78,349 deaths
• Per 10 bpm increase in RHR: all-cause mortality RR 1.09 (95% CI 1.07–1.12); cardiovascular mortality RR 1.08 (95% CI 1.06–1.10)
• RHR >80 bpm vs. lowest category: all-cause mortality RR 1.45 (95% CI 1.34–1.57); cardiovascular mortality RR 1.33 (95% CI 1.19–1.47)
• Association was independent of conventional cardiovascular risk factors (blood pressure, cholesterol, diabetes, smoking, physical activity)

RHR category	All-cause mortality RR	CV mortality RR
Lowest category (reference)	1.00	1.00
Per 10 bpm increase	1.09 (1.07–1.12)	1.08 (1.06–1.10)
>80 bpm vs lowest	1.45 (1.34–1.57)	1.33 (1.19–1.47)

Aune 2017 — Nutrition, Metabolism & Cardiovascular Diseases dose-response meta-analysis ²

• 87 prospective studies (largest RHR meta-analysis by study count)
• Per 10 bpm increase: coronary heart disease RR 1.07 (95% CI 1.05–1.10); heart failure RR 1.18 (95% CI 1.10–1.27); cardiovascular disease RR 1.15 (95% CI 1.11–1.18); all-cause mortality RR 1.17 (95% CI 1.14–1.19)
• J-shaped association for atrial fibrillation — RR 0.97 (95% CI 0.92–1.02) per 10 bpm increase; lower RHR is not associated with lower AF risk observationally (and MR evidence suggests the opposite — see Mendelian Randomization section below)
• Positive dose-response confirmed across all cardiovascular mortality endpoints

Nauman 2010 — HUNT cohort (sex-stratified analysis) ⁴

• n = 24,999 men + 25,089 women; HUNT (Norwegian population) cohort; 18.2-year follow-up
• Per 10 bpm increase in RHR: women <70 years — 18% higher risk of ischaemic heart disease death; men — 10–11% higher risk
• High physical activity substantially attenuated the RHR–IHD mortality association in women (not significantly in men)
• Interaction between RHR and physical activity level: high physical activity partially compensates for elevated resting rate on mortality risk

Dimension	Status
Pathway conserved in humans?	yes — direct human cohort data
Effect conserved across sexes?	yes — stronger in women in some cohorts
Replicated in humans?	yes — multiple independent cohorts, meta-analyses

Mendelian Randomization Status

mendelian-randomization: partial — multiple large GWAS instruments exist; two-sample MR has been conducted; results are heterogeneous across endpoints and reveal an important counter-intuitive finding.

van de Vegte 2023 — Nature Communications (largest RHR GWAS + MR) ⁵

• Meta-analysis of 100 studies, up to n=835,465 individuals; identified 493 independent genetic variants across 352 loci associated with RHR
• Two-sample MR of genetically elevated RHR found:
  • Increased dilated cardiomyopathy risk (consistent with high-RHR harm)
  • Decreased atrial fibrillation risk (inverse association — lower genetically predicted RHR → more AF, not less)
  • Decreased ischemic stroke and cardio-embolic stroke risk (also inverse — higher RHR appears protective for stroke in MR)
  • No evidence for a linear or non-linear genetic association between RHR and all-cause mortality — the large observational mortality associations are not supported by genetic causal inference
• The discrepancy with earlier one-sample MR studies is attributed to weak-instrument bias at lower p-value thresholds in single-sample analyses

Klevjer 2023 — Europace (RHR→AF MR) ⁶

• Linear and non-linear MR using HUNT (n=69,155; 7,062 AF cases) and UK Biobank (n=431,852; 20,452 AF cases)
• Inverse causal association between genetically predicted RHR and AF: OR 0.95 (95% CI 0.93–0.98) per unit RHR increase in HUNT; OR 0.96 (95% CI 0.95–0.97) in UK Biobank
• Non-linear MR supports inverse linear association for RHR below 90 bpm
• Clinical implications: rate-lowering drugs (beta-blockers, ivabradine) reduce RHR acutely, but the chronic AF risk calculus based on genetically predicted RHR may differ from pharmacological RHR reduction

Nordeidet 2024 — European Journal of Preventive Cardiology (sex-specific GWAS) ⁷

• Genome-wide meta-analysis in n=550,467
• 403 independent SNPs for RHR in total; sex-specific genetic architecture identified
• High genetically predicted RHR: increased hypertension and dilated cardiomyopathy risk; decreased atrial fibrillation risk — consistent with van de Vegte 2023

Summary of MR picture:

Endpoint	Observational RHR effect	MR result	Concordant?
All-cause mortality	Higher RHR → more deaths	No MR causal signal	No
Cardiovascular mortality	Higher RHR → more deaths	Not directly tested	—
Dilated cardiomyopathy	Higher RHR → more risk	MR confirms	Yes
Atrial fibrillation	Lower RHR → more AF (J-shape)	MR: lower RHR → more AF (inverse)	Yes
Ischaemic stroke	Higher RHR → more strokes?	MR: higher RHR → fewer strokes	No

The MR null for all-cause mortality (despite very strong observational HR per 10 bpm) suggests the observational relationship is substantially confounded — likely by cardiorespiratory fitness, autonomic dysfunction, and underlying disease. This does NOT mean that interventions that lower RHR (exercise, beta-blockers) are ineffective; they improve multiple cardiovascular parameters simultaneously beyond the isolated effect of RHR on mortality. gap/contradictory-evidence

RHR as the Cyclic-Count Driver for Arterial Pulsatile Fatigue

In the simulator’s causal model, RHR drives the cumulative pulsatile mechanical load on the aortic and large-artery walls. The mechanism:

• Each heartbeat delivers a pressure pulse that cyclically stretches and relaxes the aortic wall
• The aorta sustains approximately 2.5–3.5 billion cardiac cycles over a human lifespan (at 60–70 bpm × 70 years)
• Elastin fibers — the primary load-bearing structures during physiological arterial expansion — have finite fatigue life under repeated mechanical cycling, leading to micro-fracture accumulation and eventual structural failure gap/unsourced — the Tadic 2018 review (cited by the seeder) is a CV risk prediction review and does not establish elastin fatigue biology; a dedicated biomechanics citation is needed here
• Higher resting heart rate = more cycles per unit time → accelerated elastin fatigue burden
• As elastin fails, stiffer collagen fibers bear more of the circumferential load → pulse wave velocity rises → arterial stiffening

This cyclic-load hypothesis is supported by:

• Johansen 2012 (PLoS One, PMID 22629363): heart rate was among the strongest independent predictors of aortic pulse wave velocity progression over 16 years in men
• The cross-sectional association between 24-h ambulatory mean heart rate and augmentation index / PWV in essential hypertension ⁸ (note: this study measured 24-h mean heart rate, not clinic resting heart rate)
• The theoretical argument that bradycardic athletes show lower age-related PWV increases (though this specific causal attribution needs stronger prospective MR support) gap/no-mechanism — the elastin-fatigue mechanism is mechanistically plausible but has not been directly demonstrated in human longitudinal studies with interventional evidence; the MR evidence for heart rate → arterial stiffness is not established

See arterial-stiffening for the downstream phenotype; atherosclerosis for overlap with atherogenesis; chronic-inflammation for inflammatory contribution to arterial wall remodeling.

Intervention Responsiveness

Aerobic exercise training (primary modality)

Aerobic (endurance) training consistently reduces RHR in adults across all ages. The Reimers 2018 systematic review and meta-analysis (191 studies) found all exercise types decreased RHR; endurance training and yoga were the only modalities that significantly reduced RHR in both sexes ⁹:

• Endurance training: typically −5 to −15 bpm depending on baseline RHR, training volume, and fitness level; reductions correlate positively with baseline RHR (greatest reductions in the most deconditioned)
• Reductions correlate negatively with participant age (attenuated training-induced bradycardia in older adults — consistent with intrinsic SA node aging)
• Aerobic exercise in hypertension (n=1,787 across 34 trials): each 30 minutes/week aerobic exercise reduces RHR by approximately 1.08 bpm (95% CI −1.46 to −0.71) ¹⁰
• Mechanism: enhanced vagal (parasympathetic) tone is the dominant mechanism; increased stroke volume from cardiac remodeling also reduces the rate needed to maintain resting cardiac output

Beta-blockers (pharmacological)

Beta-1 adrenergic receptor antagonists are the most potent pharmacological RHR-lowering drugs, reducing resting rate by 10–20+ bpm depending on agent and dose. They act by blocking sympathetic chronotropic input to the SA node. This pharmacological reduction is not equivalent to exercise-induced bradycardia in terms of downstream effects:

• Beta-blocker bradycardia: reduced chronotropy without the fitness, vagal-tone, or stroke-volume adaptations
• Exercise bradycardia: accompanies stroke-volume increase, improved VO₂max, enhanced HRV, and vagal tone — multisystem adaptation

Ivabradine

Selective I_f (funny current) channel inhibitor; reduces SA node firing rate without affecting contractility or blood pressure. Used in chronic heart failure to lower HR when beta-blockers are contraindicated or insufficient. Provides relatively isolated chronotropic reduction.

Factors that elevate RHR (interventions targeting these may secondarily lower RHR)

Driver	Direction	Notes
Deconditioning / sedentary lifestyle	Raises RHR	Primary modifiable driver
Obesity	Raises RHR	Adipose inflammation, reduced vagal tone
Chronic psychological stress	Raises RHR	HPA/sympathetic activation
Caffeine	Raises RHR acutely	Acute sympathomimetic; chronic adaptation partial
Hyperthyroidism	Raises RHR	Thyroid hormone sensitizes SA node to catecholamines
Anemia	Raises RHR	Compensatory increase to maintain O₂ delivery
Sleep deprivation	Raises RHR	Sympathetic activation, HRV suppression

Hallmark Linkage

Hallmark	Connection
mitochondrial-dysfunction	Mitochondrial inefficiency → reduced cardiac efficiency, impaired autonomic control
chronic-inflammation	Elevated IL-6, TNF-α suppress parasympathetic tone and promote sympathetic dominance, raising RHR; arterial wall inflammation contributes to structural remodeling independent of pulsatile load
deregulated-nutrient-sensing	Metabolic syndrome and insulin resistance are associated with elevated RHR and reduced HRV — AMPK/mTOR dysregulation in cardiac autonomic control is hypothesized but not mechanistically established gap/no-mechanism

RHR as a Personal Longitudinal Biomarker

RHR is one of the most accessible continuous biomarkers available via consumer wearables:

• Tracking frequency: Overnight resting HR from a chest strap or optical wearable (Garmin, Polar, Whoop, Oura) provides daily estimates; spot measurements via ECG app or manual pulse are equally valid
• Target range for aging context: <60 bpm is associated with lowest mortality quartile in most cohorts; 60–70 bpm is low-risk; >80 bpm is consistently in elevated-risk territory ¹
• Trend interpretation: A rising multi-week RHR trend (e.g., +5–8 bpm above personal baseline) is a reliable indicator of overtraining, early illness, sleep debt, or deconditioning — actionable even without knowing the causal direction
• Goodhart limitation: Unlike handgrip strength, RHR is not meaningfully gameable — you cannot train specifically to lower resting heart rate without actually improving fitness or autonomic tone; the measurement reflects genuine physiology
• Clinically meaningful change: A sustained ≥5 bpm increase from personal baseline warrants investigation; a sustained 5–10+ bpm decrease over 12 weeks of aerobic training is a measurable fitness signal

Limitations and Gaps

1. MR null for all-cause mortality — the large observational mortality associations are not reproduced in genetic causal inference; confounding by fitness, disease burden, and metabolic health is likely substantial. RHR should be interpreted as a risk marker and fitness integrator rather than a causally independent driver of mortality beyond these confounders. gap/contradictory-evidence

2. Atrial fibrillation paradox — both observational J-shaped and MR inverse associations suggest lower RHR is associated with higher AF risk. Chronically low RHR from vagal dominance or SA-node disease may be arrhythmogenic. Very low RHR (<40 bpm, especially in non-athletes) warrants rhythm monitoring. gap/no-mechanism — the biological pathway from low genetically predicted RHR to AF is not established; vagal-mediated AF (short refractory period) is one hypothesis

3. Arterial stiffness mechanism — the cyclic-pulsatile elastin fatigue model is mechanistically compelling but relies on cross-sectional and limited prospective evidence; MR support for heart rate as a causal driver of arterial stiffening has not been established separately from general cardiovascular risk. gap/no-mechanism

4. Device accuracy — consumer PPG devices measure RHR with ~±5 bpm accuracy vs ECG; wrist-worn devices are less accurate than chest-strap devices for individual resting measurements. Cross-device comparisons in longitudinal tracking require caution. gap/dose-response-unclear

5. Physiological vs pathological bradycardia — the lowest RHR categories carry lowest mortality in the observational data, but extreme bradycardia (<40 bpm) from SA node dysfunction rather than vagal training has a very different prognosis. Validated instruments cannot distinguish these without rhythm analysis.

6. Sex differences — Nauman 2010 found stronger RHR-IHD associations in women; Nordeidet 2024 found sex-specific GWAS architecture. Whether intervention responses differ by sex is not well characterized. gap/needs-replication

Cross-References

• heart-rate-variability-biomarker — sibling vital-sign biomarker; the beat-to-beat counterpart that indexes vagal/parasympathetic modulation directly, whereas RHR is the mean-rate readout; both decline in autonomic terms with age and are bidirectionally tied to inflammatory tone
• vo2max-biomarker — fitness sibling; VO₂max and RHR are both cardiovascular/autonomic fitness markers; inverse correlation within individuals; VO₂max has stronger and better-characterized mortality dose-response
• arterial-stiffening — downstream phenotype driven partly by cumulative pulsatile load
• atherosclerosis — co-occurring cardiovascular phenotype; RHR associated with CV mortality via overlapping mechanisms
• exercise — primary intervention for RHR reduction; aerobic training is the best-validated modality
• chronic-inflammation — inflammatory tone and RHR are bidirectionally linked
• mitochondrial-dysfunction — cardiac mitochondrial health and autonomic control

Footnotes

Footnotes

1. doi:10.1503/cmaj.150535 · Zhang D, Shen X, Qi X · CMAJ 2016;188(3):E53–E63 · meta-analysis · n=1,246,203 (46 prospective studies; 78,349 deaths) · per 10 bpm increase: all-cause mortality RR 1.09 (95% CI 1.07–1.12); CV mortality RR 1.08 (1.06–1.10); RHR >80 vs lowest: all-cause RR 1.45 (1.34–1.57) · model: humans (general population) · PMID: 26598376 ↩ ↩² ↩³

2. doi:10.1016/j.numecd.2017.04.004 · Aune D, Sen A, ó’Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ · Nutr Metab Cardiovasc Dis 2017;27(6):504–513 · systematic review + dose-response meta-analysis · 87 prospective studies · per 10 bpm: CHD RR 1.07 (1.05–1.10); heart failure RR 1.18 (1.10–1.27); CVD RR 1.15 (1.11–1.18); all-cause mortality RR 1.17 (1.14–1.19); J-shaped for AF · model: humans · PMID: 28552551 ↩ ↩²

3. doi:10.1111/eci.12892 · Tadic M, Cuspidi C, Grassi G · Eur J Clin Invest 2018;48(3):e12892 · review of prospective cohorts and meta-analyses · higher RHR independently predicts adverse cardiovascular events; association generally stronger in men; persists after adjustment for traditional CV risk factors · model: humans · PMID: 29355923 ↩

4. doi:10.1136/jech.2009.093088 · Nauman J, Nilsen TIL, Wisloff U, Vatten LJ · J Epidemiol Community Health 2010;64(2):175–181 · prospective cohort (HUNT study) · n=24,999 men + 25,089 women; 18.2-yr follow-up · per 10 bpm: women <70 yr — 18% higher IHD death risk; men — 10–11% higher; high physical activity attenuated association in women · model: community-dwelling Norwegian adults · PMID: 20056969 ↩

5. doi:10.1038/s41467-023-39521-2 · van de Vegte YJ, van der Harst P et al. · Nature Communications 2023;14(1):4892 · GWAS meta-analysis + Mendelian randomization · up to n=835,465 (100 studies); 493 variants, 352 loci · MR: higher genetically predicted RHR → increased dilated cardiomyopathy; decreased AF, ischaemic stroke, cardio-embolic stroke; no association with all-cause mortality · model: humans (predominantly European ancestry) · PMID: 37532724 ↩

6. doi:10.1093/europace/euad292 · Klevjer M, Brumpton BM, Morin SN, Wisloff U, Nauman J · Europace 2023;25(9):euad292 · Mendelian randomization (linear + non-linear; HUNT + UK Biobank) · HUNT n=69,155 (7,062 AF cases); UK Biobank n=431,852 (20,452 AF cases) · inverse causal association RHR→AF: OR 0.95 (95% CI 0.93–0.98) HUNT; 0.96 (0.95–0.97) UK Biobank · model: humans · PMID: 37738632 ↩

7. doi:10.1093/eurjpc/zwae092 · Nordeidet AN, Brumpton BM, Wisloff U, Nauman J, Klevjer M · Eur J Prev Cardiol 2024;31(8):963–972 · GWAS meta-analysis; n=550,467 · 403 independent SNPs (total); sex-specific genetic architecture; high genetically predicted RHR: higher hypertension + dilated cardiomyopathy risk; decreased AF risk · model: humans · PMID: 38437179 ↩

8. doi:10.1016/j.ijcard.2004.04.014 · Lekakis JP, Zakopoulos NA, Protogerou AD et al. · Int J Cardiol 2005;102(3):391–395 · cross-sectional; 24-h ambulatory mean heart rate was an independent predictor of augmentation index and estimated aortic PWV in 72 untreated mild-to-moderate essential hypertension patients · PMID: 16004882 ↩

9. doi:10.3390/jcm7120503 · Reimers AK, Knapp G, Reimers CD · J Clin Med 2018;7(12):503 · systematic review + meta-analysis · 191 interventional studies (121 endurance, 43 strength, 15 combined endurance+strength, 21 yoga, 5 tai chi, 3 qigong, 5 school sport, 2 unspecified) · all exercise types decreased RHR; only endurance training and yoga significantly decreased RHR in both sexes; reductions correlated positively with baseline RHR, negatively with participant age · model: humans · PMID: 30513777 ↩

10. doi:10.1038/s41440-023-01467-9 · Jabbarzadeh Ganjeh B, Zeraattalab-Motlagh S, Jayedi A et al. · Hypertension Research 2024 · meta-analysis of randomized trials; n=1,787 across 34 trials · each 30 min/week aerobic exercise: RHR −1.08 bpm (95% CI −1.46 to −0.71; n=23 trials); dose-dependent nonlinear relationship observed for SBP/DBP; SBP greatest reduction at 150 min/week · model: humans with hypertension · PMID: 37872373 ↩